2-Methoxyestradiol (2-ME) has been reported to have antiangiogenic and antitumor activity. Its biomedical application is limited due to its poor water solubility resulting in its low bioavailability. Poly(organophosphazenes) containing
l-isoleucine ethyl
ester, ethyl-2-(O-glycyl)lactate, and α-amino-ω-methoxy-poly(
ethylene glycol) 550 were synthesized having M(W) of 35-38 kDa and polydispersity index of 2.38-2.73. Using a viscometer, the thermosensitivity useful for locally
injectable drug delivery was verified. The aqueous
polymer solution showed a
sol state at a low temperature and transformed to a gel state at body temperature. The
polymer solution (10 wt%) enhanced the solubility of
2-ME by about 10(4) times compared to that of
phosphate buffered saline.
2-ME was released from the
hydrogel mainly by diffusion, hydrophobic interaction, and surface erosion of the matrix. This release profile could be confirmed through an in vitro release test as a function of
polymers and the concentration of
2-ME in
hydrogels. By monitoring
tumor volume and CD31 immunohistochemical staining in mouse orthotopic
breast tumor (MDA-MB-231) model, it was found that the
hydrogel containing a relatively low concentration (15 mg/kg) of
2-ME showed the improved antitumor and antiangiogenic activity relative to the original formulation. This research suggests that the developed formulation of poly(organophosphazenes) may have
injectable carrier potentials for
2-ME and other lipophilic drugs.